Japanese Clinical Practice Guideline for Head and Neck Cancer
Ken‐ichi Nibu(Japan Cancer Society), Takashi Nakatsuka(Shizuoka University), Toshitaka Nagao(Tokyo Medical University), Naomi Kiyota(Kobe University Hospital), Nobuhiro Hanai(Aichi Cancer Center), Iwai Tohnai(Saitama Medical University), Nobuya Monden(Shikoku Cancer Center), Ryuichi Hayashi(National Cancer Center Hospital East), Takahiro Asakage(Tokyo Medical and Dental University), Takeshi Kodaira(Aichi Cancer Center), Akihiro Homma(Hokkaido University), Sadamoto Zenda(National Cancer Center Hospital East), Tetsuo Akimoto(Tokyo Women's Medical University), Yoshihiro Kimata(Okayama University), Koichi Omori(Kyoto University), Naoki Otsuki(Kobe University), Takashi Fujii(Saitama Cancer Center), Seiji Kishimoto(Social Insurance Saitama Chuo Hospital), Torahiko Nakashima(National Kyushu Medical Center), Hirofumi Fujii(High Energy Accelerator Research Organization), Yuzuru Kamei(Nagoya University), Hiroya Kitano(Yokohama City University), Kazuto Matsuura(National Cancer Center Hospital East), Ken Omura(Ebina General Hospital), Kazuyoshi Kawabata(Kameda Medical Center), Hiroya Ojiri(Jikei University School of Medicine), Takeshi Beppu(Saitama Cancer Center), Tadaaki Kirita(Nara Medical University)
Cited by 67
Related Papers
Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
|New England Journal of Medicine|2016|5.1k
Nivolumab vs investigator’s choice in recurrent or metastatic squamous cell carcinoma of the head and neck: 2-year long-term survival update of CheckMate 141 with analyses by tumor PD-L1 expression
|Oral Oncology|2018|802
Exploration of Tumor-Suppressive MicroRNAs Silenced by DNA Hypermethylation in Oral Cancer
|Cancer Research|2008|618
Anatomic Variations and Technical Problems of the Anterolateral Thigh Flap: A Report of 74 Cases
|Plastic & Reconstructive Surgery|1998|493